Medication info
Rosuvastatin Calcium 5 mg Tablet

Rosuvastatin Calcium 5 mg Tablet

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›5.2mg / 1 tablet
Manufacturer / importer
RP Bio Co., Ltd.
Appearance
Yellow round film-coated tablets
Packaging
30 tablets (15 tablets/PTP*2)
Approval status
Active

MFDS item code 201603490 · Approved 2016.06.15 · Insurance code 661604750

Summary

Main use
Treatment of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
Who uses it
Adults · Children
Adult dosage
The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. Elderly patients: No dose adjustment is necessary. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this drug to patients with moderate renal impairment. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this drug to patients with active liver disease. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Children's dosage
Aged 10 to 17 years: The usual dose range is 5 milligrams ∼ 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) Younger than 10 years: Safety and efficacy have not been established.

Ingredients

Manufacturer
RP Bio Co., Ltd.

Efficacy & effects

Treatment of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease

  • Hypercholesterolemia
  • hyperlipidemia
  • familial hypercholesterolemia
  • atherosclerosis
  • dysbetalipoproteinemia
  • risk factors for cardiovascular disease
  • stroke risk
  • myocardial infarction risk
View approved original text

This medication is primarily used as an adjunct to diet in patients with hypercholesterolemia. It is helpful when primary hypercholesterolemia or mixed hyperlipidemia is not controlled by diet and exercise alone. It is particularly used in patients with homozygous familial hypercholesterolemia, in conjunction with dietary measures or other lipid-lowering therapies. It effectively lowers total cholesterol and LDL cholesterol levels, delaying the progression of atherosclerosis. This medication is also used in pediatric patients aged 10 to 17 with familial hypercholesterolemia who meet certain criteria. It is utilized as an adjunct to dietary measures in patients with primary dysbetalipoproteinemia and helps reduce the risk of stroke, myocardial infarction, and arterial revascularization in high-risk adult patients with elevated high-sensitivity C-reactive protein levels. Therefore, this drug is effectively used for various dyslipidemias and the reduction of cardiovascular disease risk.

Dosage and Administration

Adult dosage

The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. Elderly patients: No dose adjustment is necessary. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this drug to patients with moderate renal impairment. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this drug to patients with active liver disease. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.

Children's dosage

Aged 10 to 17 years: The usual dose range is 5 milligrams ∼ 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) Younger than 10 years: Safety and efficacy have not been established.

Precautions

This medication should not be used in certain patients. First, patients with an allergy to this medication should not take it. Additionally, individuals with severely impaired liver function or unexplained elevation of liver enzymes should not be given this medication. Patients with muscle disease, those taking the immunosuppressant cyclosporine, and patients with severely reduced kidney function should also avoid this medication. Women who are pregnant or breastfeeding, and women of childbearing age who are not using appropriate contraception should not take this medication. High-dose administration is prohibited in patients at high risk for muscle disease. Patients with genetic metabolic disorders such as lactose intolerance should also avoid this medication. This medication should be used cautiously in patients with a history of excessive alcohol consumption or liver disease. It is important to repeat liver function tests before and during treatment to monitor liver status. Patients with hypercholesterolemia due to hypothyroidism or nephrotic syndrome should use this medication after treating the underlying conditions. This medication can cause myalgia, myopathy, and in rare cases, a serious muscle-wasting condition called rhabdomyolysis. If symptoms such as muscle pain, weakness, or cramps occur during treatment, notify healthcare professionals immediately, and if necessary, blood tests should be performed to check for muscle damage. If there are severe muscle-related adverse effects or significant increases in blood test values, administration of the medication may need to be discontinued. This medication should be administered with caution in patients with reduced kidney function, hypothyroidism, a history of muscle diseases, alcohol abuse, and those aged 70 and older due to the increased risk of adverse muscle reactions. Additionally, this medication may increase blood levels, raising the risk of muscle toxicity when used in conjunction with certain drugs, so it is important to consult with healthcare providers regarding any co-administered medications. In particular, it should be avoided in combination with fibrate drugs, and high-dose administration is prohibited. Safety during pregnancy and breastfeeding has not been established, so it should not be used in these populations, and women of childbearing potential should ensure they are using appropriate contraception. In cases of overdose, there is no specific antidote; thus, treatment should be symptomatic, and liver and muscle enzyme tests should be monitored. This medication does not significantly affect the ability to drive or operate machinery, but caution should be used as dizziness and other symptoms may occur. Finally, during the course of taking this medication, abnormalities such as liver function abnormalities, muscle pain, and skin rashes may occur, and immediate consultation with healthcare professionals is necessary if these symptoms arise.

Side effects

Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ophthalmoplegia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorder, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal hepatic failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, fatigue, numbness, paresthesia, chest discomfort, appetite loss, abdominal distension, syncope, generalized pain

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to prevent exposure to air or moisture, and it is best kept at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain the medication's effectiveness and prevents degradation.

Appearance and packaging

Appearance

Yellow round film-coated tablets

Package unit

30 tablets (15 tablets/PTP*2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.